Insider · CIK 0002075079
Richard Charles Donohoe
Files at HCMA (HCM III ACQUISITION CORP.), HACQ (HCM IV Acquisition Corp.). First filing -, latest -.
Richard Charles Donohoe files SEC Form 4 as director at HCMA (HCM III ACQUISITION CORP.), and also at HACQ (HCM IV Acquisition Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard Charles Donohoe has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | HACQ HCM IV Acquisition Corp. | JOther Class B Ordinary Sharesderivative | +25,000 | $0.00 | $75 | 25,000 | Feb 18, 2026 |
| Jul 31, 2025 | HCMA HCM III ACQUISITION CORP. | JOther Class B Ordinary Sharesderivative | +25,000 | $0.00 | $100 | 25,000 | Aug 5, 2025 |
Questions about Richard Charles Donohoe
Answered from the filings on this page, as of the latest one.
Is Richard Charles Donohoe buying or selling?
Richard Charles Donohoe has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard Charles Donohoe's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard Charles Donohoe has 0.
Where does Richard Charles Donohoe file Form 4?
Richard Charles Donohoe has filed Form 4 at HCMA (HCM III ACQUISITION CORP.); HACQ (HCM IV Acquisition Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.